Tinea Pedis Treatment Market Growth Outlook Through 2024-2033

Overview and Scope
Tinea pedis treatment refers to the various medical interventions and self-care practices aimed at alleviating the symptoms and eradicating the fungal infection known as athlete’s foot. Antifungal drugs, both topical and oral, are often used to eradicate the fungus that is causing the illness and reduce symptoms including itching, redness, and inflammation, prevent the spread of the infection to other parts of the body.

Sizing and Forecast
The tinea pedis treatment market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to rising incidence of infectious disorders, ancient remedies, discovery of Antifungals, Over-the-Counter (OTC) Products and medical education.

The tinea pedis treatment market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to globalization, travel, drug resistance, economic factors and public health campaigns. Major trends in the forecast period include Innovative drug delivery systems, medical advancements, advancements in pharmaceutical technology and nanotechnology.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/tinea-pedis-treatment-global-market-report

Segmentation & Regional Insights
The tinea pedis treatment market covered in this report is segmented –

1) By Drug Class: Antifungals, Combinations
2) By Route of Administration: Oral, Topical
3) By Disease Indication: Interdigital Tinea Pedis, Plantar Tinea pedis, Vesicular Tinea Pedis
4) By Distribution Channel : Hospital Pharmacies , Retail Pharmacies , E-commerce

North America was the largest region in the tinea pedis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tinea pedis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15684&type=smp

Major Driver Impacting Market Growth
The escalating incidence of foot and ankle injuries is expected to propel the growth of the tinea pedis treatment market going forward. Foot and ankle injuries are any damage or trauma sustained to the bones, ligaments, tendons, muscles, or other tissues in the foot or ankle region, often resulting from accidents, sports activities, or repetitive stress. The factors, including lifestyle changes, rising participation in sports and physical activities, inadequate footwear, improper training techniques, prone to falls and degenerative conditions, cause foot and ankle injuries. Additionally, the prevalence of obesity and chronic diseases like diabetes further exacerbates the risk of foot and ankle complications. Ankle and foot injuries can exacerbate tinea Pedis treatment by creating favorable conditions for fungal growth and prolonging periods of inactivity. For instance, in November 2023, according to Howden Group Holdings Ltd, a UK-based insurance intermediary company, the severity of ankle injuries in the English Premier League increased by 170% from October 2022 to January 2023 after the FIFA World Cup Qatar 2022. Therefore, the Escalating incidence of foot and ankle injuries drives the Tinea pedis treatment market.

<h4 class=reporthtag>Impact of Increasing Fungal Infection Prevalence on the Tinea Pedis Treatment Market</h4>

The increasing prevalence of fungal infections is expected to propel the growth of the tinea pedis treatment market going forward. Fungal infections are diseases caused by fungi that can infect various body parts. The prevalence of fungal infections is caused by weakened immune status, environmental conditions favoring fungal growth, exposure to fungi, underlying health conditions, occupational exposure, and personal hygiene practices. The treatment of tinea pedis aims to eliminate the fungal infection and relieve the associated symptoms. For instance, in July 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, fungal infection-related hospitalizations reached a total of 59,212 by 2021, with the rate of these hospitalizations increasing from 25.0 in 2020 to 26.8 in 2021 per 10,000 hospitalizations, with an average annual increase of 8.5%. Therefore, the increasing prevalence of fungal infections drives the growth of the tinea pedis treatment market.

Key Industry Players
Major companies operating in the tinea pedis treatment market are McKesson Corporation, Pfizer Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Almirall S.A., Exeltis USA Inc., Taro Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Ego Pharmaceuticals Pty. Ltd., Fougera Pharmaceuticals Inc., Camber Pharmaceuticals Inc, Mayne Pharma Group Limited, Sun Pharmaceutical Industries Ltd., CorePharma LLC, Blueberry Therapeutics Ltd.

The tinea pedis treatment market report table of contents includes:

1. Executive Summary
2. Tinea Pedis Treatment Market Characteristics
3. Tinea Pedis Treatment Market Trends And Strategies
4. Tinea Pedis Treatment Market – Macro Economic Scenario
5. Global Tinea Pedis Treatment Market Size and Growth
.
.
.
32. Global Tinea Pedis Treatment Market Competitive Benchmarking
33. Global Tinea Pedis Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tinea Pedis Treatment Market
35. Tinea Pedis Treatment Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model